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 Campylobacter spp. are a leading cause of sheep abortions worldwide; 
Campylobacter fetus ssp. fetus has historically been the major culprit. Increasingly, however, 
C. jejuni has been isolated from cases of sheep abortion, and it has now replaced C. fetus ssp. 
fetus as the predominant cause of Campylobacter-related ovine abortion in the United States. 
Emergence of a single tetracycline resistant clone (clone SA) has been implicated as the 
primary reason for this shift. Virulence factors for clone SA have still not been completely 
elucidated, and it is not known how this bacterium reaches the uterine and placental tissue 
from the gut. Although an effective animal model has been described, development of an in 
vitro cell culture model would provide a cost-effective and reliable alternative.  
 In this study, we assessed the ability of IA3902, a clinical isolate of clone SA, to 
invade and survive within two different cell lines, AH-1 ovine placental trophoblasts and 
RAW264.7 murine macrophages. Our results indicate that IA3902 is actually less invasive 
and has lower survival within AH-1 trophoblast cells than the nonabortigenic isolate 
NCTC11168; in contrast, IA3902 displayed increased invasion and survival in RAW 
macrophages as compared to NCTC11168. Next, we tested the hypothesis that C. jejuni’s 
invasive abilities in AH-1 cells would be enhanced in the presence of progesterone, which is 
present in high levels in the serum of ewes at the time that C. jejuni abortion typically occurs. 
Contrary to our hypothesis, progesterone treatment of AH-1 cells actually decreased invasion 
of C. jejuni into trophoblasts. Finally, we developed a system of mCherry fluorescent protein 
expression in both IA3902 and NCTC11168 to facilitate noninvasive detection of bacteria in 
an in vitro system. mCherry was successfully expressed in Campylobacter as observed via 
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fluorescent microscopy and measured using a fluorospectrometer; however, low background 
fluorescence values and an apparent fitness cost in mCherry-expressing Campylobacter may 
limit its utility for certain studies. These findings indicate that C. jejuni clone SA’s ability to 
survive within immune cells may provide the driving force for its high abortigenicity, rather 
than an increased tropism for placental tissues. They also provide a basis for future use of in 
vitro systems for the study of clone SA, and identify RAW264.7 murine macrophages as a 




CHAPTER I. GENERAL INTRODUCTION 
 
Introduction 
 Campylobacter is a small, Gram negative bacteria that is among the leading causes of 
food-borne gastrointestinal disease worldwide. The most common culprit of gastrointestinal 
disease, C. jejuni, is estimated to affect nearly 1.3 million persons per year in the United 
States alone (1), and outbreaks of food-borne campylobacteriosis have steadily increased 
since 2009 (2). Worldwide, C. jejuni is responsible for 5-14% of all diarrheic disease (3). 
Despite the Healthy People 2020 objective target of reducing incidence to 8.5 cases per 
100,000 people in the United States by the year 2020 (4), the incidence of Campylobacter 
has remained unchanged or slightly increased in recent years, and preliminary 2013 estimates 
put the current incidence at 13.8 cases per 100,000 people (5). The cost of human 
campylobacteriosis in the United States each year is estimated to be between 1.5 and 6.8 
billion dollars (6,7). It is evident that the burden of disease is substantial; however, due to its 
more fastidious culture characteristics, much less is known about this organism than many 
bacteria causing similar disease, e.g. E. coli or Salmonella.  
 Campylobacter infections occur at all ages, but are more prevalent in children under 
5; other influencing factors include seasonality (increased incidence during summer months), 
infecting strain (variations in virulence exist among strains), and socioeconomic status, 
among others (7,8). Transmission to humans occurs via a variety of sources, including 
consumption of contaminated milk, food, or water, and contact with infected pets or livestock 
(9). By far the most frequent source, however, is contaminated undercooked poulty products 
(10-12). Chickens (and, to a lesser extent, turkeys and ducks) can be colonized with C. jejuni 
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from a relatively early age without showing any overt signs of disease (9,13). Campylobacter 
is highly infectious; infective doses as low as 500 to 800 cfu have been reported in human 
patients (14). After infection, C. jejuni colonizes the intestine and may result in clinical signs 
ranging from a mild, watery diarrhea to severe, bloody diarrhea requiring hospitalization. 
Rarely, post-infection sequelae such as reactive arthritis, Guillain-Barré syndrome (GBS), or 
Miller-Fischer syndrome may result (7).  
 In addition to poultry, Campylobacter spp. are also widespread among livestock; 
most often, they colonize the intestinal tract without causing any clinical signs, but they may 
be associated with important illnesses, including infertility and abortion in ruminants 
(10,15,16). Abortions due to Campylobacter are an important management problem in the 
sheep industry, and can cause major economic losses to producers; reported abortion rates in 
affected flocks range from 5-50% (17). Disease occurs following an initial oral exposure, 
with subsequent bacteremia, placentitis, fetal infection, and abortion; typically, abortions due 
to C. jejuni are seen during the last trimester of pregnancy (17).  
 In the past, Campylobacter-related abortions have been largely attributed to C. fetus 
spp. fetus; however, ongoing work at Iowa State University has demonstrated that a single 
tetracycline-resistant clone of C. jejuni, clone SA, has gained predominance in the United 
States (18,19). The exact mechanisms of this strain’s high pathogenicity are as yet unknown. 
Use of an established pregnant guinea pig model has allowed demonstration of this strain’s 
high abortigenicity (20) as well as elucidation of a critical virulence factor, LuxS (21), and a 
combination of genomic- and proteomic-based approaches has recently shed more light on 




 In order to study the pathogenesis of this strain in greater detail, an in vitro cell 
culture model would be of great value. The identification of a cell line in which clone SA 
shows high levels of invasion and/or survival as compared to non-abortigenic isolates would 
allow us to quickly and inexpensively identify potential virulence factors of this strain. 
Combination of an in vitro model with a simple bacterial tag, such expression of a 
fluorescent protein, would further simplify quantification and would allow for tracking of C. 
jejuni intracellularly without the need for cellular destruction. Here, we report recent progress 
in development of an in vitro model system for characterization of highly abortifacient C. 
jejuni clone SA, as well as the development of a fluorescent protein expression system in C. 
jejuni. The outcomes of this study further our understanding of clone SA’s pathogenesis, and 
identify a potential cell line for further development as an in vitro modeling system.  
 
Thesis Organization 
 This thesis consists of two chapters. The first chapter is a literature review, which 
includes a general overview of Campylobacter pathogenesis and epidemiology (focusing on 
C. jejuni), as well as a review of cellular and animal model systems. The second chapter 
describes the development of a cellular model for characterization of invasion and 
intracellular survival of clone SA, as well as the development of a fluorescent protein 
expression system in that strain. References cited throughout the text can be found 












The first published account of Campylobacter is attributed to Theodore Escherich in 
1886 (23); the bacteria were further described in 1913 by John McFadyean and Stewart 
Stockman, who were investigating a flock of sheep with an abortion rate approaching 33%. 
In smears of uterine mucus, they identified an organism which they accurately characterized 
as comma-shaped and actively motile, with some end-to-end joining producing long spiral 
forms (24,25). After an apparently identical organism was identified in aborting cattle just a 
few years later, the organism was named Vibrio fetus (25,26).  
In the years following, Vibrio continued to be identified, primarily by veterinarians, 
and by 1944 two further species, Vibrio jejuni and Vibrio coli, had been identified from the 
feces of cattle and pigs, respectively (25,27). These organisms remained in the Vibrio genus 
until 1963, when Sebald and Véron placed V. fetus into a new genus, Campylobacter, based 
on its microaerophilic nature and low G+C content (28). Ten years later, Véron and Chatelain 
performed more comprehensive studies, and classified four distinct species (C. fetus ssp. 
fetus, C. fetus ssp. venerealis, C. coli, and C. jejuni) into the Campylobacter genus (23,29).  
 
1.2 Classification 
The family Campylobacteraceae now contains two genuses, Campylobacter and 
Arcobacter. There are currently 25 species in the Campylobacter family (30), and at least 14 
of these have been isolated from cases of human disease (23). However, C. jejuni and C. coli 
together account for >95% of human Campylobacter infections (31), and are the focus of 
most efforts to control campylobacteriosis.  
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As a genus, Campylobacter are small (0.2-0.8 µm x 0.5-5 µm), Gram-negative, 
slender, curved rods (23). They are sometimes referred to as "gull-shaped" organisms 
because of their tendency to join end-to-end and form "S" or "V" shapes. They have low 
G+C content, ranging from 29 to 47 percent of molar weight (23). These organisms are 
microaerophilic, and optimal growth is achieved in an environment containing 5% O2, 10% 
CO2, and 85% N2 (27,32). A restricted temperature range for growth is also seen, with the 
optimal temperature for most species being 37˚C (C. jejuni, C. coli, and C. lari being the 
notable exceptions that grow optimally at 42˚C); no growth is seen at temperatures below 
30˚C (32). These two characteristics, taken together, place severe restrictions on growth 
outside of an animal host, and preclude multiplication (though not survival) in food during 
storage and processing (27,32).  
The majority of the species are motile via a single polar unsheathed flagellum at one 
or both ends of the cell. Notable exceptions are C. gracilis, which is nonmotile, and C. 
showae, which has multiple flagellae (27). Energy is obtained via amino acids or 
tricarboxylic acid cycle intermediates; Campylobacter species do not readily ferment or 
oxidize carbohydrates (23,27). Most strains are resistant to cephalothin - a fact which is often 
used in their laboratory identification (16)- and resistance to fluoroquinolones is emerging 
(33).  
 
1.3 Epidemiology of Human Infections 
 The most common causes of campylobacteriosis, primarily C. jejuni and, to a lesser 
extent, C. coli, are ubiquitous in the environment as well as in the intestinal tracts of wild 
birds and many mammalian species. C. jejuni in particular is able to colonize the intestinal 
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tract of chickens without causing any overt disease in this species (9). Cattle are another 
common reservoir, though estimates vary widely; the prevalence of the pathogen in the 
digestive tract of healthy cattle has been shown to range from 0.8% - 80% (15,34-38).   
 Humans are infected most commonly when handling or ingesting raw or undercooked 
poultry (10-12); infection can also occur after contact with cattle or consumption of 
contaminated beef or raw milk (27). These two sources together are thought to account for 
more then 90% of human infections (10). Less common sources of infection include other 
food animal species (sheep, pigs, turkeys, ducks), domestic animals (cats, dogs, ferrets), 
contaminated water, and shellfish. Sheep are commonly colonized (39,40), with shedding 
rates often approaching 100% near the time of lambing (39). Most are colonized within 1-5 
days of birth (39), and remain so throughout life; a recent study showed the majority of sheep 
and goat carcasses at slaughter were contaminated with Campylobacter (41).  
 Major limitations in data availability have thwarted attempts to measure the exact 
impact and prevalence of campylobacteriosis. Commonly, official estimates are derived from 
laboratory-based surveillance, but this probably represents only a very small fraction of those 
infected (42). Studies in the United States, England and Wales, and the Netherlands have 
estimated that for every reported Campylobacter infection, there are between 7 to 38 persons 
that actually become ill (43-45). In addition to mild unreported illnesses, seroconversion 
studies show a poor correlation between antibody detection and any gastrointestinal illness, 
and seroconversion rates far outstripped estimates of disease prevalence in several European 





1.4 Disease Syndromes  
1.4.1 Human gastroenteritis 
Despite its impact on foodborne and gastrointestinal disease worldwide, 
Campylobacter's role and significance in this regard wasn't recognized until the 1970's 
(25,47). Prior to that time, it had been considered largely a reproductive pathogen of animals. 
This may seem surprising at first glance; however, its fastidious and slow-growing nature 
allows it to be easily overgrown in fecal cultures by the facultative anaerobes (e.g., E. coli) 
unless selective culture techniques are utilized. Advances in microbiological techniques have 
greatly improved our ability to detect and isolate Campylobacter from mixed populations, 
especially fecal and environmental samples.  
Following ingestion, C. jejuni will colonize the lower intestinal tract. Infections may 
be asymptomatic; where clinical signs occur, they are typically self-limiting and include 
fever, vomiting, and watery or bloody diarrhea with abdominal pain. Although most 
infections are mild, severe dehydration can result and some patients may require 
hospitalization (9).  In fact, Campylobacter are estimated to account for about 17% of 
hospitalizations resulting from food-borne infections, and for 5-6% of food-borne illness 
related deaths (44). Recent estimates by the CDC implicate Campylobacter in over 8,000 
food-borne illness-related hospitalizations annually in the United States, a figure surpassed 
only by Salmonella spp. and Norovirus (1). In rare cases, bacteria entering the bloodstream 






1.4.2  Extraintestinal Disease in Humans 
Rarely, long term complications may ensue after campylobacteriosis, the most serious 
being development of Guillain-Barré syndrome (GBS).  This is an acute demyelinating 
polyneuropathy characterized by flaccid paralysis; disease onset is typically 1-2 weeks 
following an acute infectious illness (50). While other viruses and bacteria can initiate GBS, 
C. jejuni is by far the most frequent cause, with documented evidence of recent infection 
with this pathogen in 30-40% of GBS cases (51,52). The pathogenesis of GBS results when 
an immune-mediated response against the gangliosides is triggered by an immunologically 
similar antigen on the bacterium. Studies of O-side chain serotypes of the 
lipooligosaccharides have revealed that certain Campylobacter serotypes, in particular O:19, 
are linked to GBS (52,53). In addition to GBS and the GBS variant Miller Fisher Syndrome 
(MFS) (50), increased incidences of inflammatory bowel disease (54) and reactive arthritis 
(55) have been correlated with a prior history of campylobacteriosis.  
 
1.4.3 Ovine abortion 
 Campylobacter species have long been associated with genitourinary disease in cattle, 
sheep, goats (16), and, rarely, humans (56). Sheep are the main species in which placental 
and fetal infection is common, and ovine campylobacteriosis typically manifests as late term 
abortions; in bovids, early embryonic death and/or infertility are more common (16).  
 There are two main species of Campylobacter associated with ovine abortion, C. fetus 
ssp. fetus and C. jejuni. Clinically, abortions caused by either species are identical, and it is 
not possible to distinguish the two without further testing (16). Abortions occur late in 
pregnancy (during the last 6 weeks, or approximately days 105-150); infected ewes may also 
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have diarrhea, depression, an elevated temperature, and/or vaginal discharge several days 
prior to parturition (16). High levels of Campylobacter are shed in aborted fetal and placental 
tissues, and when a naïve flock is exposed to these materials, an abortion storm can result in 
which up to 50% of ewes may abort (57). Frequently, aborted fetuses lack specific lesions 
due to in utero autolysis; where histology is possible, necrosis is seen in the chorionic villi 
with arteriolitis and leukocyte infiltration into the lamina propria (16,58). Bronchopneumonia 
and hepatitis are also common findings in the fetus (58). Diagnosis is by culture and/or 
observation of the organisms in placental smears, and is substantiated by histopathology; 
serology is not useful as a diagnostic tool as many sheep can carry the organism in the 
intestine and gall bladder without showing any clinical signs (39,40). 
Historically, most ovine abortions were attributed to Campylobacter fetus ssp. fetus, 
while C. jejuni had been thought of as largely a gastrointestinal pathogen (16). Based on a 
report that C. jejuni could also be a cause of abortion (59), Hedstrom et al. inoculated 
pregnant ewes with intravenous C. jejuni at days 114 and 123 of gestation, and found that all 
ewes aborted at 7-12 days post-inoculation, with no other clinical signs beyond an elevation 
in rectal temperature prior to abortion (58).  Since that time, abortions due to C. jejuni have 
increasingly been recognized in North America (18,60), and it has now replaced C. fetus ssp. 
fetus as the predominant cause of Campylobacter-related ovine abortion in the United States. 
In a study of ovine abortion isolates from Iowa, California, Idaho, Oregon, Nevada, and 
South Dakota during 2003-2007, it was found that 68 of 74 Campylobacter isolates were C. 
jejuni. Strikingly, 93% of those C. jejuni isolates belonged to a single genetic clone, named 




Further studies have confirmed the widespread nature of C. jejuni clone SA (which 
belongs to MLST sequence type [ST]-8) in sheep flocks United States (19); additionally, this 
clone has been associated with human gastrointestinal infections following consumption of 
raw milk (61). Tetracycline resistance would seem to be a major factor driving the 
predominance of clone SA; use of this drug is common in sheep flocks in the United States, 
especially as it is the only class of antibiotics approved for control and prevention of 
Campylobacter abortion storms in this country (18). In Great Britain, where use of 
tetracyclines in livestock is highly restricted, less than 5% of C. jejuni isolates from cases of 
ruminant abortions were resistant to this class of antibiotics (19). Supporting the importance 
of tetracycline resistance, the tet(O) gene-- the main gene providing tetracycline resistance to 
Campylobacter (62)-- is invariably found on the chromosome in clone SA, whereas it is more 
typically plasmid-borne (19,22).  
While tetracycline use may provide a driving force for the spread of clone SA, its 
extreme predominance in U.S. flocks suggests that other factors are at play as well; this is 
especially true given that other genotypes of C. jejuni can carry tetracycline resistance, albeit 
much less commonly associated with abortions. Virulence factors of clone SA are not well 
understood, and it is not known exactly how this bacterium reaches the uterine and placental 
tissues from the gut. However, clone SA has been shown to have a distinct transcriptomic 
and proteomic profile from the human isolate NCTC11168 (which was shown to be non-
abortifacient in a pregnant guinea pig model (20)), despite high genomic sequence homology 
between these two strains (22). In particular, transcription of genes for energy production and 
conversion, motility, and anaerobic respiration are upregulated in IA3902 (a representative 
isolate of clone SA) while transcription of genes encoding iron uptake systems and utilization 
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of proline, glutamate, aspartate, and lactate are downregulated (22). Additionally, there are 
notable genetic differences between the two strains in the regions encoding for synthesis and 
modification of capsule and flagellin (22).  
 
1.5 Pathogenesis 
A number of confirmed or putative virulence factors have been identified in C. jejuni, 
including capsular polysaccharides (CPS) and lipooligosaccharides (LOS), adhesins, protein 
glycosylation, flagella/motility, and the cytolethal distending toxin (CDT) (63). Here, we will 
focus on CPS/LOS, adhesins, and flagella, which are the factors most associated with cellular 
infection and invasion. 
 
1.5.1 Capsular polysaccharides (CPS)/Lipooligosaccharides (LOS) 
 In contrast to many other enteric pathogens, C. jejuni express both a capsular 
polysaccharide (CPS) and a lipooligosaccharide (LOS) in lieu of a full-length 
lipopolysaccharide (LPS) (64). The CPS and LOS produced by different strains are highly 
variable and structurally complex, and many genes are further subject to phase variation (65); 
this inherent genetic and phenotypic diversity aids in thwarting immune system responses 
and adaptation to various environmental conditions.  
 Probably the best characterized role of LOS in Campylobacter pathogenesis is its 
relationship to Guillian-Barré syndrome (GBS), which is discussed in further detail above. 
The LOS in certain strains of C. jejuni mimic the human gangliosides on peripheral nerves, 
leading to autoimmune demyelination and severe neurologic deficits (52). While a number of 
studies have shown increased sensitivity to various antimicrobial compounds in LOS mutants 
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(66-69), no direct role in pathogenesis has to date been identified. Additionally, no alterations 
in cellular invasion have been seen in C. jejuni harboring mutations in several individual 
genes of the LOS cluster (70); however, large scale deletion of the LOS biosynthesis region 
did abolish cellular invasion (68). Thus, the definitive role of LOS in Campylobacter 
pathogenesis remains somewhat murky.  
 Polysaccharide capsules are, in general, very important virulence structures in the 
bacteria that express them (64); this also seems to be the case in C. jejuni, although the role 
of CPS in disease is incompletely understood. In C. jejuni, the capsule genes are arranged 
into three regions, where region 2 contains genes encoding the synthesis of specific capsular 
polysaccharides, and regions 1 and 3 contain transport and assembly genes such as kpsM, 
kpsE, kpsS, and kpsC (64). A mutant deficient in the CPS transporter gene kpsM has been 
shown to have a modestly reduced ability to invade INT-407 cells in vitro and reduced 
virulence in a ferret-based disease model (71). Similarly, a study by Bachtiar et al. showed 
that a kpsE mutant had reduced invasiveness in vitro and reduced colonization of chickens 
compared to the wild-type strains (72). Paradoxically, C. jejuni seems to reduce its 
expression of surface capsular polysaccharides when co-cultured with intestinal epithelial 
cells (73); however, in that study, there was correspondingly reduced cellular invasion when 
capsular synthesis was decreased. Similar to the situation in many other pathogens, one of the 
roles of CPS in C. jejuni seems to be in mediating resistance to complement-mediated killing 
(69,71); whether this is required to initiate colonization or after invasion has not yet been 






 A variety of human and non-human origin cell lines have been utilized to study the 
interaction of C. jejuni with host cells, and these have led to the identification of a number of 
putative adhesion or binding factors. These include the fibronectin-binding outer membrane 
protein CadF (74), the surface lipoprotein JlpA (75), the periplasmic binding protein PEB1 
(76), and the major outer membrane protein (MOMP) (77), among others. CadF is expressed 
in all strains of C. jejuni and C. coli, although the gene varies slightly between the two 
species. CadF's importance as a virulence factor was demonstrated by experiments showing 
that wild-type C. jejuni bound to and invaded INT-407 epithelial cells much more efficiently 
than wild-type C. coli; when isogenic cadF mutant strains were created, this difference in 
cellular invasion was significantly reduced (78). In addition to its role as a binding protein, 
CadF seems to be important in triggering bacterial internalization via a Rho GTPase 
signaling pathway (79). JlpA is a 42.3-kDa protein that has previously been reported as 
mediating C. jejuni adherence by binding to Hsp-90 on the surface of HEp-2 epithelial cells 
(80). A more recent investigation utilizing targeted mutagenesis has disputed this finding and 
contends that PEB3, and not JlpA, is required for host cell binding (81). Flanagan et al. also 
reported mutagenesis of JlpA did not significantly alter binding to epithelial cells, while 
CadF and FlpA seem to play important roles in colonization (82). 
 The major outer membrane protein (MOMP), also called PorA, is one of two porins 
identified to date in C. jejuni (77,83). It is important in the envelope structure of the bacteria 
(83), and was also investigated as a vaccine candidate (84,85). Mutational analysis of MOMP 
has been difficult to achieve, as mutations in porA are probably lethal to the bacterium (82). 
However, its importance in binding to intestinal epithelial cells has been demonstrated via 
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immunoblotting (77). It has also recently been identified, along with the flagellar protein 
FlaA, as a blood group antigen binding agent that is required for chicken colonization (86). 
Although immunity to C. jejuni is largely strain-specific, the sera of human patients 
recovering from C. jejuni has been repeatedly shown to contain antibodies against MOMP 
(84,85,87,88), and vaccination utilizing a recombinant MOMP has been shown to provide 
some protection against heterologous strains in a mouse intestinal colonization model (89), 
further reinforcing the idea that it is of key importance in establishing bacterial pathogenicity. 
  
1.5.3 Flagella/Motility 
 Campylobacter jejuni possesses a single, polar flagellum that is essential in its ability 
to colonize mammalian hosts and invade eukaryotic cells (90). The first evidence of its 
importance in virulence came from studies by Black et al., who fed human volunteers a 
mixture of motile and non-motile phase variants and thereafter recovered only motile forms 
from stool samples (14). Subsequent studies have confirmed the requirement for motility in 
intestinal colonization in a variety of animal models, including mice (91), chickens (92), 
rabbits (93), and ferrets (94). 
 The flagellum is composed of two flagellin monomers, FlaA and FlaB, which are 
encoded by flaA and flaB, respectively. Both monomers are required for expression of a 
normal flagella and motility; however, loss of flaA seems to be more detrimental, as this 
causes a severely truncated flagella that is greatly reduced in motility (95). Mutants of flaA 
are unable to efficiently colonize intestinal cells in vitro (96,97); similarly, other mutations 
affecting motility completely or near completely eliminate internalization into intestinal 
epithelial cells (98-101). However, in the case of flaA, this effect may not entirely be due to 
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the decrease in motility; Wassenaar et al. showed that flaA mutants showed a severe deficit in 
their ability to colonize chickens regardless of motility conferred by FlaB flagellae (102).  
 Another important function of the flagellar apparatus in Campylobacter is protein 
secretion. The flagellum serves as a type III secretion system (T3SS) and secretes both 
flagellar and non-flagellar proteins (103-105).  A set of proteins termed the "Campylobacter 
invasion antigens", or Cia, require intact flagella for their successful secretion (103) and are 
integral in cellular infection. In particular, CiaB is required for the invasion of INT-407 cells 
(103,106,107) and contributes to induction of apoptosis in a THP-1 macrophage model (108). 
Mutants defective in CiaB also show severe deficits in their ability to colonize chicks (109). 
CiaC is not required for host cell invasion but mutants do show a reduction in cellular 
internalization in INT-407 cells (110). CiaI mutants show a defect in intracellular survival as 
well as increased colocalization of the lysosomal marker cathepsin D with the 
Campylobacter-containing vacuole (CCV; see below) (111). Mutation of a secreted flagellar 
protein, FlaC, results in no morphological changes in the flagella but causes a severe deficit 
in invasion of HEp-2 cells (105). Lastly, apart from their roles in motility and protein 
secretion, flagellae are associated with other important functions, including biofilm formation 
(112,113) and autoagglutination (114). Taken together, the data provide compelling evidence 
that flagellae and their associated components are crucial for the interaction of C. jejuni and 
host cells.  
 
1.6 Interaction with Eukaryotic Cells 
By virtue of its microaerophilic, temperature-specific nature, C. jejuni has necessarily 
developed a close relationship with the vertebrate gastrointestinal tract. However, details of 
  
16 
its interactions with host cells are as yet poorly understood, especially in comparison to other 
intestinal pathogens such as E. coli and Salmonella. There do appear to be three critical 
factors for a successful interaction between C. jejuni and host cells: (1) the ability to facilitate 
its own uptake into host cells, (2) the ability to elude or modulate delivery to host lysosomes, 
and (3) the ability to alter host cell gene expression and thereby stimulate production of 
proinflammatory cytokines (115).  
It has been clearly demonstrated via both examination of biopsy samples from human 
patients naturally infected with C. jejuni (116) as well as experimental infection of primates 
(117) and in vitro infection of human intestinal epithelial cells (118) that C. jejuni is able to 
gain intracellular access to these nonphagocytic cells. It is not completely understood how 
this occurs or what bacterial factors may be important, and many of the forces at work are 
likely to be multifactorial and complex. To complicate the issue, C. jejuni displays marked 
differences in colonization ability among strains, and genomic instability during intestinal 
colonization of humans, chickens, and mice has been shown (119-122).  
 Several mechanisms for C. jejuni's uptake into intestinal epithelial cells have been 
proposed, though none have yet been proven. What is known is that C. jejuni's uptake into 
cells seems to markedly differ from that of many common pathogens. Many pathogens, 
including Salmonella enterica serovar Typhimurium (123-125),  Listeria monocytogenes 
(126-128), and Shigella flexneri (129-132) rely heavily upon actin-mediated mechanisms for 
their successful uptake into host cells. In contrast, Oelschlaeger et al. demonstrated that 
uptake of C. jejuni is actin-independent, and disruption of the actin cytoskeleton does not 
prevent its invasion (133).  In fact, disruption of the actin cytoskeleton has been shown to 
actually increase the efficiency of C. jejuni cellular uptake (134).  The internalization process 
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for C. jejuni appears instead to be dependent upon microtubules, and administration of drugs 
that cause microtubule depolymerization will prevent its uptake (133). Cholesterol-, 
glycolipid-, and sphingolipid-enriched domains in the cell membrane called lipid rafts or 
caveolae may also play an important role in C. jejuni's internalization process, and it has been 
shown that sequestration of host cholesterol inhibits C. jejuni entry into cells (135). One 
study utilizing a dominant interfering mutation of the caveolae-associated protein caveolin-1 
in the T84 human intestinal epithelium cell line demonstrated that this protein is required for 
efficient uptake of C. jejuni into intestinal epithelial cells (134). It has also been pointed out, 
however, that Caco-2 cells lacking caveolin-1 (and thus, caveolae) are still efficiently 
colonized, and Caco-2 cells engineered to produce caveolin-1 do not show increased 
bacterial internalization (136). Subsequent siRNA knockdown studies in HeLa cells have 
shown that non-caveolae cholesterol-rich cell membrane domains, rather than caveolae 
themselves, are integral in internalization, while caveolin-1 plays a role in the ensuing signal 
cascade (136).  
On the bacterial side, motility seems to be an essential factor in efficient intestinal 
cell colonization, as was previously discussed. However, nonmotile mutants are still 
recovered from models of in vitro infection, albeit at low levels, suggesting that this is not an 
absolute requirement (101). Adhesins are integral to the process of binding and 
internalization, and have also been discussed above. CadF may play a particular role, in that 
it seems to both bind to cells and trigger the internalization process (79). Proteins secreted 
through the flagellar apparatus such as CiaB and CiaC also seem to be be integral to the 
binding and internalization process; however, their exact roles in this process remain 
undefined, and as Watson and Galán point out, evidence to support a direct role of any 
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flagellar component or secreted protein in directly triggering bacterial entry is scant at best 
(115). Mutations affecting protein glycosylation or capsular synthesis also affect invasion 
into host cells. However, the role of protein glycosylation may be related to motility, in that 
glycosylation is essential for flagellar assembly (137); a direct role has yet to be established. 
Stronger evidence exists for the role of the polysaccharide capsule in cellular invasion, and 
knockout mutants of a number of capsular transport and assembly genes have consistently 
borne this out (69,71,72,97). In contrast, mutants in which the LOS core structure is severely 
truncated show no alteration in their ability to invade Caco-2 cells, despite increased 
susceptibility to complement-mediated killing and decreased intracellular survival time (65). 
Once actually inside the cell, Campylobacter resides within a specialized 
compartment that has been termed the Campylobacter-containing vacuole, or CCV 
(134,138,139). In macrophages, the CCV efficiently fuses with the phagolysosomal 
compartment and rapid killing is typically accomplished (134). However, in epithelial cells, 
the CCV avoids fusion with lysosomes, and the bacteria are able to survive within the CCV 
(134); the mechanism causing this alteration in the canonical endocytic pathway is unclear. 
Most studies have reported a loss in viability after about 24 hours within intestinal epithelial 
cells (139-141); one study, utilizing a 48 hour "preculture" period under strictly anaerobic 
conditions to recover C. jejuni following the invasion of T84 cells and live/dead staining 
coupled with FACS analysis, reported that there was no loss in viability at 24 hours and 
suggested that there may be a shift in the physiologic state of the bacterium within epithelial 
cells such that it becomes extremely oxygen-sensitive (134).  
Intestinal epithelial cells are capable of mounting a robust innate immune response 
(142), and induction of proinflammatory cytokines by these cells, such as IL-8, is a major 
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step in the pathogenesis of campylobacteriosis. The proinflammatory state induced by 
Campylobacter is a consequence of the activation of NF-κB and the MAP kinase signaling 
pathways (143-145); however, the mechanism of activation appears to be unusual, as it is 
independent of TLR2, TLR4, NOD1, or NOD2 activation (146). It has also been proposed 
that cytolethal distending toxin, the only toxin produced by C. jejuni that has thus far been 
characterized (115), may directly stimulate cytokine production via DNA damage (147). 
Simultaneously, an anti-inflammatory pathway is also activated via the phosphotidylinositol-
3 kinase/Atk pathway (145), which may represent an attempt by the bacterium to overcome 
the host inflammatory response and thus prolong intracellular survival.  
 
1.7 Model systems for the study of campylobacteriosis 
Despite its worldwide prevalence and economic importance, many questions clearly 
still remain regarding the pathogenesis of genitourinary disease caused by Campylobacter 
spp. The lack of a reliable, inexpensive, and reproducible animal model for in vivo study has 
been a major roadblock to more extensive study. A model utilizing pregnant Guinea pigs is 
currently the most well-established and reliable laboratory model of abortion, in that they are 
susceptible to infection and clinical signs are similar to those seen in sheep (148-150). This 
model has been successfully utilized for the study of clone SA (20,21,151); however, studies 
have been hampered by expense and handling limitations, and large-scale experiments are 
impractical. Mouse models have been used with some success to demonstrate bacteremia 
(152,153), but not reproductive disease. Chickens are a utile and commonly employed model 
for colonization studies (97,154,155); the usefulness of this model in the study of mammalian 
reproductive processes is nevertheless, by definition, limited. Use of an ovine model would 
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clearly be prescient, and has been employed in past studies (58,156); again, their use is 
limited by expense, as well as housing and animal welfare considerations. Additionally, 
many sheep can be silent carriers with no overt clinical symptoms of campylobacteriosis, 
thus necessitating extensive screening and/or strict sourcing requirements prior to 
undertaking experimental infections.  
In light of these difficulties, development of a cellular model for the study of 
abortifacient C. jejuni is clearly of pressing concern. A number of in vitro models have been 
used successfully to study the interaction of C. jejuni with intestinal epithelial cells and 
immune cells.  Epithelial cell lines which have been utilized include the polarized human 
colorectal cell line Caco-2 (118,157,158), the nonpolarized intestinal line INT-407 
(98,133,159,160), and cell lines of human cervical provenance including HEp-2 
(139,161,162)  and HeLa (136,143), among others. A variety of immune cells have also been 
utilized for the study of Campylobacter, include the murine macrophage lines RAW264.7 
(163) and J774 (164,165), bone marrow derived macrophages (166,167) and dendritic cells 
(166,168). 
 Despite the wealth of information these studies have yielded regarding intestinal and 
immune cell pathogenesis, to date no study (to the author's knowledge) has attempted to 
study the pathogenesis of highly abortigenic C. jejuni in vitro. The multifactorial nature of 
the abortion syndrome makes identifying a single paramount cell line a daunting task; 
however, several cell types seem to be good candidates to elucidate at least portions of 
disease pathology. Histopathology of aborted placental and fetal tissues in animals infected 
with C. jejuni has consistently shown a strong tropism for placental trophoblasts and 
inflammatory cells (20,58). The AH-1 ovine placental trophoblast cell line was derived by 
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Haldorson et al. in 2006 to study the pathogenesis of Neospora caninum (169), but has not 
yet been utilized in the study of Campylobacter.  
 In order to cause abortion, C. jejuni must first translocate to the uterus and placenta 
from its normal location in the gastrointestinal tract, and evidence exists that this strain is 
able to cause septicemia at a high rate after oral inoculation (20). It is not known, however, 
whether Campylobacter travels free in the bloodstream or is ferried within inflammatory 
cells; one study utilizing a gfp-expressing strain of C. jejuni showed high association with 
neutrophils and (to a lesser extent) macrophages in the bloodstream of experimentally 
inoculated mice (122). Due to their high numbers in the intestinal tract and robust 
accumulation in placental tissues, macrophages seem a likely candidate for C. jejuni 
translocation. Although a variety of macrophage lines have been utilized in the study of 
Campylobacter, the vast majority of these studies have focused on relatively well-
characterized strains such as 81-176 and NCTC11168; it is not known whether clone SA 
invades or survives in these cells at a different rate than these strains. If survival were greatly 
improved, abortion might be less a function of increased tropism for placental tissue than of 
increased systemic bacterial load. Regardless of the cell culture system utilized, the 
identification of a cell line allowing robust and differential growth of clone SA as compared 
to non-abortigenic strains of C. jejuni would afford a method of quickly identifying and 
characterizing key virulence factors without the expense and difficulty of animal models.  
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Abstract 
 Campylobacter spp. are a leading cause of sheep abortions worldwide; 
Campylobacter fetus ssp. fetus has historically been the major culprit. Increasingly, however, 
C. jejuni has been isolated from cases of sheep abortion, and it has now replaced C. fetus ssp. 
fetus as the predominant cause of Campylobacter-related ovine abortion in the United States. 
Emergence of a single tetracycline resistant clone (clone SA) has been implicated as the 
primary reason for this shift. Virulence factors for clone SA have still not been completely 
elucidated, and it is not known how this bacterium reaches the uterine and placental tissue 
from the gut. Although an effective animal model has been described, development of an in 
vitro cell culture model would provide a cost-effective and reliable alternative.  
 In this study, we assessed the ability of IA3902, a clinical isolate of clone SA, to 
invade and survive within two different cell lines, AH-1 ovine placental trophoblasts and 
RAW264.7 murine macrophages. Our results indicate that IA3902 is actually less invasive 
and has lower survival within AH-1 trophoblast cells than the nonabortigenic isolate 
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NCTC11168; in contrast, IA3902 displayed increased invasion and survival in RAW 
macrophages as compared to NCTC11168. Next, we tested the hypothesis that C. jejuni’s 
invasive abilities in AH-1 cells would be enhanced in the presence of progesterone, which is 
present in high levels in the serum of ewes at the time that C. jejuni abortion typically occurs. 
Contrary to our hypothesis, progesterone treatment of AH-1 cells actually decreased invasion 
of C. jejuni into trophoblasts. Finally, we developed a system of mCherry fluorescent protein 
expression in both IA3902 and NCTC11168 to facilitate noninvasive detection of bacteria in 
an in vitro system. mCherry was successfully expressed in Campylobacter as observed via 
fluorescent microscopy and measured using a fluorospectrometer; however, low background 
fluorescence values and an apparent fitness cost in mCherry-expressing Campylobacter may 
limit its utility for certain studies. These findings indicate that C. jejuni clone SA’s ability to 
survive within immune cells may provide the driving force for its high abortigenicity, rather 
than an increased tropism for placental tissues. They also provide a basis for future use of in 
vitro systems for the study of clone SA, and identify RAW264.7 murine macrophages as a 
suitable cell culture model for further pathogenesis studies.  
 
Introduction 
 Campylobacter is a small, Gram-negative, comma-shaped bacterium that is a 
common cause of food-borne gastrointestinal disease worldwide. One of the most common 
culprits of gastrointestinal disease, Campylobacter jejuni, is estimated to affect nearly 1.3 
million persons per year in the United States alone (1). In addition, Campylobacter spp. 
consistently rank among the most prominent causes of infectious sheep abortions worldwide. 
Outbreaks within a flock can be devastating, with abortion rates in naïve flocks reaching up 
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to 50% (2,3). Historically, C. fetus ssp. fetus has been the major culprit identified in ruminant 
genitourinary disease. In the late 1980's, it began to be recognized that C. jejuni was also 
capable of causing abortion (4,5); since that time, there has been a remarkable shift in disease 
epidemiology in the United States. In the last 25 years, C. jejuni has replaced C. fetus ssp. 
fetus as the predominant cause of Campylobacter-related ovine abortion in this country (6), 
and there has been a shift from a variety of circulating strains (7) towards a single dominant 
clone. This clone is named "clone SA" (for "sheep abortion). All recent isolates of clone SA 
are tetracycline resistant (6), and this clone has also been associated with human illness after 
consumption of raw milk (8).  
 A representative isolate of C. jejuni clone SA, IA3902, has now been sequenced (9), 
and efforts are underway to more extensively characterize the factors driving its evolution, 
virulence, and abortifacient nature. Towards this end, a pregnant Guinea pig model has been 
successfully utilized for the study of clone SA pathogenesis (10,11), and has led to the 
identification of several critical virulence factors, such as LuxS (12). However, major 
limitations to this model exist, including expense, the impracticality of large-scale studies, 
and the confounding effects of handling stress in these delicate subjects. Given these 
concerns, the establishment of a reliable in vitro model to study the reproductive 
pathogenesis of Campylobacter would clearly be of great advantage. Histopathologic studies 
of abortifacient C. jejuni have shown a predilection for infection of the placental trophoblasts 
and inflammatory cells (5,10), especially the macrophages that are recruited en masse to the 
uterus and placenta during pregnancy (36). A stable line of ovine placental trophoblasts (AH-
1) has previously been derived (13) and has been used to study both Neospora (13) and 
Chlamydophila (14) but not, to the authors knowledge, in studies of Campylobacter 
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pathogenesis. Macrophages have been utilized in a number of studies to determine C. jejuni's 
ability to colonize and survive within inflammatory cells; however, no studies to date have 
elucidated clone SA's abilities in this regard. 
 During pregnancy, a number of endocrinological changes take place in the ewe. 
Serum levels of the sex hormone progesterone are high in sheep throughout pregnancy and 
increase further during the third trimester (15,16). This increase coincides with the usual 
onset of C. jejuni-induced abortion, which can occur from approximately day 108 through 
day 150 (17). In contrast, circulating estrogen levels in the ewe are typically quite low (5-20 
pg/ml) until immediately prior to parturition, at which time there is a sudden and intense 
spike in estrogen (16,18). Due to the high circulating serum hormone levels occurring during 
the peak time of Campylobacter abortion in sheep, we hypothesized that the sex hormones, 
and progesterone in particular, would enhance C. jejuni infection of AH-1 ovine placental 
trophoblasts.  
 As an additional tool towards development of an in vitro cell culture system, it was 
desirable to develop a method of quickly identifying and quantifying bacterial growth 
without the necessity of destroying cells or of recovering C. jejuni in culture, where 
difficulties can abound. Fluorescent proteins provide an ideal means of tracking bacteria, in 
that they are intrinsic, resistant to photo-bleaching, and do not require extra processing steps 
or cellular destruction for visualization. Several systems have been developed in 
Campylobacter to date, including organisms expressing green fluorescent protein (gfp) (19) 
and its derivatives cyan fluorescent protein (cfp) and yellow fluorescent protein (yfp) (20). 
However, experience with these systems in our laboratory has been mixed (O. Sahin, 
personal communication) and none have gained wide acceptance. Additionally, if use in in 
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vivo as well as in vitro studies is desired (e.g., monitoring subjects for the development of C. 
jejuni septicemia), a protein with fluorescence in the far-red spectrum would achieve better 
tissue penetration, and thus better detection, than gfp-based proteins. The "mFruit" family of 
fluorescent proteins includes a number of monomeric fluorescent proteins in a range of 
colors that were derived from the tetrameric protein DsRed via a combination of directed 
evolution and random mutagenesis (21). Of these, the fluorescent protein mCherry offers a 
very short maturation time (t0.5 = 15 minutes at 37˚C), excellent pH resistance (pKa < 4.5), 
and high photostability (t0.5 = 68 seconds) (21,22).  Additionally, it has one of the longest 
emission wavelengths of the mFruit proteins (610 nm), facilitating deeper tissue penetration 
and making it an excellent candidate for noninvasive in vivo imaging. Creation of a strain of 
C. jejuni able to stably express this protein would allow for high resolution in vivo tracking 
of bacterial infection in susceptible animals.  
 The aims of this study were thus threefold: 1) to characterize two likely cellular 
models (AH-1 ovine placental trophoblasts and RAW264.7 murine macrophages) for in vitro 
study of the pathogenesis of infection with the highly abortifacient C. jejuni clone SA; 2) to 
determine whether the sex hormones progesterone and ß-estradiol would enhance C. jejuni's 
invasion of or persistence in AH-1 ovine placental trophoblasts; and 3) to develop and 
characterize a system of mCherry fluorescent protein expression in C. jejuni and determine 
its suitability for further use in in vitro and in vivo models.  
 
Materials and Methods 
 
Bacterial strains, plasmids, and growth conditions. All isolates of C. jejuni were routinely 
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cultured from frozen stocks (-80˚C) onto Mueller-Hinton (MH) agar or broth (Difco, 
Franklin Lakes, NJ) at 42˚C in a microaerobic atmosphere (85% N2, 10% CO2, and 5% O2) 
and passaged every 24 to 48 hours. C. jejuni IA3902 is a representative clinical isolate of 
clone SA from a case of sheep abortion that has been described previously (6). NCTC11168 
is a nonabortifacient C. jejuni isolate from a case of human enteritis (23) that was used as a 
control strain in this study. E. coli was grown in Luria-Bertani (LB) broth or agar (Difco) at 
37˚C. Where necessary, media was supplemented with chloramphenicol (Cm; 15 µg/ml).  
 
Cell culture conditions. RAW264.7 murine macrophages (ATCC #TIB-71) were routinely 
cultured in DMEM (Corning Cellgro, Tewksbury, MA) supplemented with 10 mM HEPES, 
2 mM glutamax, and 10% fetal bovine serum (Thermo Scientific, Logan, UT).  AH-1 ovine 
placental trophoblasts (obtained from Dr. Tim Baszler at Washington State University) were 
routinely cultured in Opti-MEM without phenol red (Life Technologies, Grand Island, NY) 
supplemented with 2 mM glutamax, 10 mM HEPES, and 10% fetal bovine serum. Where 
noted, this media was also supplemented with progesterone or ß-estradiol (Sigma-Aldrich, St. 
Louis, MO) at a concentration of 0.1 µg/ml or 1.0 µg/ml. Cells were seeded onto 24 and 96 
well plates at a density of 1 x 106 cells/ml approximately 3-4 hours prior to infection. Live 
cells were counted in a hemacytometer, and cell culture viability was monitored via the use 
of trypan blue dye exclusion.  
 
Gentamicin Protection Assays. C. jejuni internalization and survival assays were carried 
out in a similar manner as described previously (24). Fresh cultures of C. jejuni were grown 
for 16-20 hours in MH broth on a shaker in microaerobic conditions, followed by 
  
43 
centrifugation at 8,000 rpm for 10 minutes and removal of supernatant. After resuspension in 
sterile phosphate-buffered saline (PBS; Thermo Scientific), an aliquot was taken for 
measurement of OD600nm via spectrophotometer (Bio-Rad smartspectm3000, Hercules, CA) 
and cultures were diluted in sterile PBS to a final concentration of 5 x 109 cfu/ml. Cells were 
then infected with either IA3902 or NCTC11168 at a multiplicity of infection (MOI) of 100. 
Infection was allowed to proceed for 2 hours, at which time the cell culture media was 
removed and cells were washed 3x with sterile PBS. Fresh cell culture media supplemented 
with 100 µg/ml gentamicin was then added and cells were incubated for a further 2 hours in 
order to destroy any remaining extracellular bacteria. Media was again removed, cells were 
washed 1x with sterile PBS, and complete culture media (without antibiotics) was added; this 
was considered T=0. Cells were lysed at 0, 12, 24, or 48 hours after infection using 0.1% 
Triton-X 100 and aliquots plated onto MH agar to determine bacterial survival. All plates 
were incubated at 42˚C for 48 hours in microaerobic conditions, after which time colony-
forming units (cfu) were counted. 
 
Preincubation of C. jejuni with sex hormones. Fresh cultures of C. jejuni were grown for 
16-20 hours in MH broth containing either no hormones or 1.0 µg/ml progesterone or ß-
estradiol on a shaker in microaerobic conditions. Bacterial cultures were then centrifuged at 
8,000 rpm for 10 minutes and the supernatant poured off. After resuspension in sterile PBS, 
an aliquot was taken for OD600nm measurement via spectrophotometer and cultures were 
diluted in sterile PBS to a concentration of approximately 5 x 109 cfu/ml. Infection of cell 




Generation of Campylobacter shuttle plasmid harboring mCherry. The mCherry gene was 
amplified using PCR from the PRSET-mCherry plasmid (a generous gift of the laboratory of 
Dr. Bryan Bellaire of Iowa State University). Primers utilized were mCherry-F3 
(CGCTTCCGCGGAAGGAGATTTAAATGGTGAGCAAGGGCGAGGAGG) and 
mCherry-R3 (TTTCGAGCTCTTACTTGTACAGCTCGTCCATGCCG); underlined 
sequences represent restriction sites for SacII and SacI, respectively. The pRY112 shuttle 
plasmid (25)  contains the selectable marker gene CmR (conferring chloramphenicol 
resistance), and our lab has previously cloned the promoter region of the cmeABC gene 
(pABC) (26) into this vector (27). This plasmid and the mCherry PCR product were serially 
digested with SacI and SacII, and ligated together. DH5α E. coli was then naturally 
transformed with the ligation product and streaked onto LB agar containing chloramphenicol 
(LB-Cm). After 24 hours of growth, colonies were harvested into LB-Cm broth, and grown 
for a further 24 hours. Plasmid isolation was performed using the Qiaprep Spin Miniprep Kit 
(Qiagen, USA) and the presence of the pABC-mCherry construct was confirmed via PCR 
using primers pABC-F (AAAAGGATCCTAAATGGAATCAATAG) and mCherry-R3. The 
resulting plasmid was designated pRY112-pABC-mCh.  
 
Transformation of C. jejuni. Strain IA3902 was naturally transformed with the pRY112-
pABC-mCh plasmid using an agar-based method as described previously (28).  Several 
attempts at natural transformation of strain NCTC11168 were unsuccessful; thus, 
electroporation was utilized for transformation of this strain as described previously (29). 
Briefly, bacteria were grown overnight and then washed 3-4 times in ice-cold wash buffer 
(272 mM sucrose, 15% glycerol). A 50 µl aliquot was then mixed with 4.0 µg of the 
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pRY112-pABC-mCh plasmid and electroporated (2.5 kV, 200 Ohms, 25 µF; Gene Pulser, 
Bio-Rad, USA). The cuvette was flushed with SOC medium (Life Technologies) and plated 
onto MH agar with chloramphenicol (MH-Cm). Colonies growing on MH-Cm agar were 
transferred to MH-Cm broth and grown overnight, after which time expression of the plasmid 
was confirmed in all strains via immunofluorescence microscopy (Olympus IX-61 inverted 
microscope; Olympus America, Center Valley, PA). PCR was also performed to confirm the 
presence of the pABC-mCherry construct using primers pABC-F and mCherry-R3. The 
resulting strains were designated 3902-mCh and 11168-mCh, respectively.  
 
Motility assay. All C. jejuni strains used in this experiment were tested for motility using 
semisolid MH agar. Strains were grown for 16-20 hours in MH broth and optical density was 
measured via spectrophotometer. After adjustment to an OD600nm value of 0.5, strains were 
inoculated into 0.4% Mueller-Hinton agar via a single stab into the center of the plate. After 
incubation under microaerobic conditions for 30h at 42˚C, the distance of swarming motility 
was measured at the widest portion of the swarm halo.  
 
Growth kinetics and fluorescence determination. In order to determine the effects of 
various substances on the growth of wild-type strains of C. jejuni as well as mCherry-
harboring strains, growth curves were performed. Fresh cultures of C. jejuni were grown for 
16-20 hours in MH broth on an orbital shaker at 160 rpm. Aliquots were then taken for 
measurement via spectrophotometer and cultures were diluted in fresh MH broth to a starting 
OD600nm of 0.05. After dilution, taurodeoxycholic acid (25 mg/ml) or acetylsalicylic acid 
(200 µg/ml) was added to the culture media. All cultures were incubated in microaerobic 
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conditions with shaking (160 rpm) at 42˚C. Aliquots were removed and OD600nm values were 
measured at the time points indicated (0, 4, 8, 12, and 24 hours); fluorescence values were 
also measured in triplicate at each time point using a fluorometer (FLUOstar Omega, BMG 
Labtech, Offenburg, Germany).  
 
Plasmid Retention Assay. To determine the retention of the pRY112-pABC-mCh plasmid 
in the absence of selective pressure, a plasmid retention assay was performed. Strains were 
inoculated from frozen stocks onto MH (wt strains) or MH-Cm (mCherry-harboring strains) 
agar and grown for 24 hours under standard culture conditions. Ten colonies of each strain 
were then selected at random and inoculated into 5 ml of MH broth without antibiotic 
supplementation. Broths were incubated microaerobically on a shaker (160 rpm) at 42˚C for 
24 hours, at which time aliquots from each strain were diluted 1000-fold (to approximately 
106 cfu/ml) and 100 µl was reinoculated into 5 ml of fresh MH broth. Passaging of strains 
continued in a similar manner every 24 hours for 20 days. On days 1, 3, 5, 10, 15, and 20, 
100 µl aliquots of 1000- and 10,000-fold dilutions of each strain were spread onto MH agar. 
Wild-type strains NCTC11168 and IA3902 were also spread onto MH-Cm agar. Plates were 
incubated under standard culture conditions for 48h. At that time, growth of wt strains on 
MH agar was verified and absence of spontaneous development of antibiotic resistance was 
confirmed via the absence of wt growth on MH-Cm plates. For strains 11168-mCh and 3902-
mCh, 100 colonies were selected at random at each time point from the MH agar plates, and 
plated in tandem onto fresh MH and MH-Cm agar plates. After incubation for 48 hours under 
standard culture conditions, growth of each colony on the two plates was compared and 
recorded. Colonies not growing on MH-Cm were restreaked from the MH agar onto a new 
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MH-Cm plate for confirmation, and PCR was utilized to test for the absence of the mCherry 
gene construct in those colonies.  
 
Immunofluorescence microscopy. Infected slides were prepared for immunofluorescence 
microscopy in a manner previously described (30). RAW cells were added to EtOH prepared 
coverslips and grown to approximately 80% confluency, at which time cells were infected 
with C. jejuni at an MOI of 100. At 30 minutes, 1 hour, 2 hours, 4 hours, 8 hours, 12 hours, 
24 hours, and 48 hours post-infection, coverslips were harvested and fixed in 4% 
paraformaldehyde in PBS for at least 24 hours at 4ºC. Monolayers were permeabilized with a 
bovine serum albumin-PBS solution containing a final concentration of 0.1% saponin (BSP 
buffer) prior to incubation with primary antibody (LAMP 1-Alexa Fluor 488; sc-19992 
AF488) for 2 hours at room temperature. Antibody was purchased from Santa Cruz 
Biotechnology (Dallas, TX) and used at a concentration of 1:200. Coverslips were then 
washed 3x with cold BSP prior to being mounted on glass slides using 1 drop of ProLong® 
Gold antifade reagent with DAPI (Life Technologies). Immunofluorescence microscopy was 
performed using an Olympus IX-61 inverted microscope equipped with blue (DAPI), red 
(mCherry), and green (Alexa Fluor 488) filter sets and a cooled CCD camera. Final images 
were prepared using ImageJ v1.48b image analysis software (Rasband, 1997). 
 
Statistical Analysis. Statistical analysis was performed using commercially available 
statistical software (JMP Pro v.10.0, SAS Institute, 2012). Differences among groups were 
analyzed using Tukey’s HSD test and were considered statistically significant at values of p 





NCTC11168 efficiently invades AH-1 ovine placental trophoblasts.  
 To determine whether AH-1 ovine placental trophoblasts might serve as a suitable in 
vitro model for infection, it was first desirable to determine whether C. jejuni is capable of 
invading and/or surviving in these cells. The human fecal isolate NCTC11168 and a 
representative isolate of the SA clone, IA3902, were used for this purpose. 
 We hypothesized that since IA3902 is highly abortigenic, it would be able to infect 
the placental trophoblasts more efficiently than the non-abortifacient isolate NCTC11168. In 
fact, our data showed precisely the opposite (Fig. 1); 11168 was able to invade (T=0) and 
persist (T=12 and later time points) within the cells more efficiently than IA3902. This 
difference was most pronounced at earlier time points (T=0 and T=12), but persisted through 
24 hours. After that time, few viable bacteria of either strain were recovered. These results 
indicate the suitability of the AH-1 cell line for the study of the pathogenic traits of C. jejuni, 
since both strains were able to invade at a relatively high rate (approximately 104 cfu/ml).  
 
Treatment of AH-1 cells with sex hormones is protective against C. jejuni invasion 
 Next, we desired to determine whether the sex hormones progesterone and ß-estradiol 
would have any effect on the receptiveness of AH-1 cells to infection with C. jejuni. 
Abortions due to C. jejuni almost invariably occur late in pregnancy, when progesterone 
levels in the serum are quite high (0.02 µg/ml) and the uterine venous concentration can 
reach 0.05 µg/ml (31,32). In contrast, levels of ß-estradiol and other estrogens are quite low 
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in the serum (5-20 pg/ml) until just prior to parturition, when a large spike occurs (with 
levels reaching up to 900 pg/ml), concurrent with a decrease in serum progesterone levels 
(16,18). It was our hypothesis that the high level of circulating progesterone might cause 
immunosuppression in the AH-1 cells and allow more efficient colonization by C. jejuni.  
 As seen in Fig. 2A, when AH-1 cells were treated for 48 hours prior to infection with 
a high dose of progesterone (1 µg/ml; PH), there is a moderate, though not statistically 
significant, decrease in invasion of 11168, as well as a significant decrease in survival of 
11168 at 12 hours. More surprisingly, there is a significant decrease in invasion of AH-1 
cells by IA3902 (Fig. 2B); no significant differences were noted in survival at 12 hours. No 
difference in survival was noted at 24 or 48 hours for either strain. Despite this, it should be 
noted that for 11168, there were several outlier wells in which abundant growth was 
unexpectedly seen after 24 or 48 hours of incubation, and these outliers were all within the 
progesterone treatment groups; no such outliers were noted for IA3902. Treatment of AH-1 
cells with a lower dose of progesterone (0.1 µg/ml; PL) had no effect on the invasion or 
intracellular survival of either strain (Fig. 2). These results are somewhat contrary to 
expectations, and are surprising given the high circulating levels of progesterone at the time 
of peak C. jejuni infection of the fetoplacental unit.  
 When AH-1 cells were treated with ß-estradiol at a low dose of 0.1 µg/ml (EL) or a 
high dose of 1.0 µg/ml (EH) for 48 hours prior to infection (Fig. 3), the only significant 
difference noted was a decrease in invasion by IA3902 (at T=0) when cells were treated with 
low-dose ß-estradiol. The significance of that difference is unclear; however, the rest of the 
data are consistent with our hypotheses. Estrogen values do not drastically alter during 
pregnancy in the ewe until immediately prior to parturition; thus, we would not expect 
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estrogens to play an important role in the pathogenesis of C. jejuni. 
 
Length of exposure of AH-1 cells to sex hormones alters magnitude of effect 
 Since a difference was seen in the ability of C. jejuni to invade AH-1 cells after 
exposure to progesterone as described above, we next asked how long cells would need to be 
exposed to this hormone in order to see that difference. Cells were exposed to a high dose of 
progesterone (1.0 µg/ml) for 48 hours, 24 hours, 3 hours, or 15 minutes prior to infection 
with either NCTC11168 or IA3902. As can be seen (Fig. 4A), cells that were unexposed to 
hormones were invaded by 11168 (T=0) at a significantly higher rate than those that were 
exposed to progesterone for either 3 hours, 24 hours, or 48 hours. There was not a significant 
difference between untreated cells and those exposed to progesterone for 15 minutes. At 
T=12, untreated cells had much higher bacterial loads than those treated for 24 or 48 hours, 
and cells treated for 15 minutes were also significantly more infected than the cells treated 
for 48 hours. By 24 hours post-infection, cells treated for 48 hours were significantly less 
infected than untreated cells or cells treated for 3 hours. At 48 hours post-infection, there was 
no difference between untreated cells and treated cells; however, significantly more 11168 
persisted in cells treated for 15 minutes than in cells treated for 24 or 48 hours prior to 
infection. Thus, treatment of AH-1 cells with progesterone for at least 24 hours prior to 
infection seems to be necessary to cause a significant decrease in C. jejuni invasion.  
 For IA3902, the differences were less pronounced (Fig. 4B). At T=0, untreated cells 
and those treated for 15 minutes or 3 hours were all significantly more invaded by C. jejuni 
than cells treated for longer periods of time (24 or 48 hours). However, by 12 hours, there 
were no significant differences in bacterial persistence. Interestingly, there were again 
  
51 
several wells with unexpected abundant growth seen at either 24 or 48 hours; these outliers 
all occurred in cells treated with progesterone for short periods (either 15 minutes or 3 
hours).  
 
Treatment of C. jejuni with sex hormones does not alter intracellular invasion or 
survival  
 To more accurately determine whether the effects of progesterone and ß-estradiol 
were due to changes in cellular protein expression or were due to effects upon the bacteria 
themselves, C. jejuni were grown in MH broth containing 1.0 µg/ml of progesterone (Pretx 
PH) or ß-estradiol (Pretx EH) for approximately 20 hours prior to infection. Bacteria were 
then pelleted via centrifugation and resuspended in sterile PBS such that any remaining 
extracellular hormone was eliminated. AH-1 cells were then infected as described above, 
with no hormones used in the cell culture media. As seen in Fig. 5, treatment of C. jejuni 
strains NCTC11168 (Fig. 5A) or IA3902 (Fig. 5B) with either progesterone or ß-estradiol did 
not significantly alter cellular invasion or intracellular survival at any of the time points 
tested.  
 
IA3902 efficiently invades RAW264.7 Murine Macrophages   
 Invasion of AH-1 ovine placental trophoblasts by IA3902 was relatively low, 
especially in comparison to the non-abortive strain NCTC11168. Thus, it was desirable to 
determine whether this invasion defect was a general property of IA3902, or was specific to 




 RAW264.7 murine macrophages were infected in the same manner as AH-1 placental 
trophoblasts, described above. As can be seen (Fig. 6), IA3902 both invaded and survived 
within macrophages more efficiently than NCTC11168 at 0, 12, and 24 hours post-infection. 
In comparison to AH-1 cells, in which survival was occasionally vigorous at 48 hours (Fig. 
1), no viable bacteria of either strain were recovered at 48 hours from the RAW264.7 murine 
macrophages.  
 
Expression of mCherry fluorescent protein in two C. jejuni strains 
 In addition to developing a viable in vitro cell culture model, it was also desirable to 
develop a method of quickly identifying and quantifying bacteria both in vitro and in vivo. To 
this end, the mCherry fluorescent protein was cloned and inserted into the pRY112 plasmid 
along with the promoter for the cmeABC gene cassette; the resulting plasmid was referred to 
as pRY112-pABC-mCh. The plasmid was successfully inserted into IA3902 via natural 
transformation and into NCTC11168 via electroporation, and its expression was confirmed 
via use of immunofluorescence microscopy (see Fig. 9b). These strains were referred to as 
3902-mCh and 11168-mCh, respectively.  
 
Characterization of C. jejuni strains expressing the pRY112-pABC-mCh plasmid 
Motility 
 Following successful transformation of both IA3902 and 11168 with the pRY112-
pABC-mCh plasmid, it was first desirous to assess the motility of the 11168-mCh and 3902-
mCh strains in comparison to their wt counterparts. As motility is one of the major virulence 
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factors identified in both cellular invasion and intestinal colonization models of C. jejuni 
infection, any reduction would greatly impair the utility of these strains as a model for 
infection. As seen in Fig. 7, no significant alteration in motility was noted in mCh-harboring 
strains as compared to their wt counterparts.  
 
Growth Curve and Baseline Fluorescence values 
 To characterize expression of the pRY112-pABC-mCh plasmid and to determine 
whether its expression had any measurable effect on cell viability, a growth curve experiment 
was undertaken (Fig. 8). Both the 3902-mCh and 11168-mCh strains were significantly 
hampered in their growth as compared to the wt strains at both 12 and 24 hours; the 
expression of this plasmid thus seems to cause a considerable fitness cost in these strains. 
 Additionally, measures of fluorescence were taken at each time point to determine the 
amount of baseline expression of the mCherry protein (Fig. 9a). As the mCherry-harboring 
strains did not grow as well as wt strains, fluorescence values were normalized to OD600nm 
values to adjust for differences in bacterial numbers. Baseline fluorescence values were not 
significantly increased over wt strains at time points prior to 12 hours. At T=12h, both the 
3902-mCh and 11168-mCh strains were significantly more fluorescent than their wt 
counterparts. At T=24h, the fluorescence of 3902-mCh was again significantly greater than 
its wt counterpart; 11168-mCh was also more fluorescent than 11168, although the difference 
was not quite significant (p = 0.0567).  
 
Induction of fluorescence using inducers of the cmeABC promoter 
 Next, we attempted to determine whether substances that are known inducers of the 
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cmeABC promoter could increase expression of the pRY112-pABC-mCh construct and thus 
increase the fluorescence of these strains. Two such inducers are acetylsalicyclic acid (33) 
and bile salts (34). Fresh cultures of 3902-mCh, 11168-mCh, and wt strains were diluted to 
an OD600nm of 0.05 and acetylsalicylic acid or a representative bile salt, sodium 
taurodeoxycholic acid, were added at a concentration of 200 µg/ml or 25 mg/ml, 
respectively.  
 Surprisingly, acetylsalicylic acid did not increase the fluorescence of the mCherry-
harboring strains (Fig. 10), and in fact actually significantly decreased the fluorescence of the 
3902-mCh strain by 24 hours. The fluorescence of the 11168-mCh strain was also decreased 
at 24 hours; however, this decrease was not quite significant (p = 0.07).  
 In contrast, taurodeoxycholic acid did significantly increase the fluorescence of both 
mCherry-harboring strains (Fig. 11). Fluorescence intensity was significantly enhanced for 
both 3902-mCh and 11168-mCh at 4 and 24 hours. At 8 and 12 hours, only 3902-mCh was 
significantly more fluorescent than its wt strain; however, the difference between 11168-mCh 
and its wt approached significance (p = 0.07). This increase in fluorescence was seen despite 
a concurrent decrease in OD600nm values and dismal growth through 24 hours; however, 
samples plated at 12 and 24 hours confirmed viability of the cells, and wt growth in the 
presence of taurodeoxycholic acid was similarly thwarted (data not shown).  
 
Stability of the pRY112-pABC-mCh construct in C. jejuni 
 As a major application of mCherry-harboring strains is to assess Campylobacter-cell 
interactions using both in vitro and in vivo models, it is important to determine the stability of 
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the plasmid to ensure that there is a correlation between loss of fluorescence and absence of 
bacteria. To this end, a plasmid retention assay was performed by serially passaging 11168-
mCh and 3902-mCh in MH broth (Fig. 12). Samples were taken at days indicated (days 1, 3, 
5, 10, 15, and 20), and 100 colonies were randomly passaged onto MH-Cm agar to determine 
the percent retaining the pRY112-pABC-mCh plasmid. Although the vast majority of 
bacteria of both strains retained the plasmid through day 5, both strains show significant loss 
of the plasmid at day 10, and have nearly completely lost the plasmid by day 20. This 
exponential loss is probably due in large part to the fitness cost the plasmid appears to 
impose (see Fig. 8), and would severely limit the usefulness of the construct for long-term 
experiments.  
 
Use of strains harboring mCherry in microscopy applications 
 Lastly, it was important to determine whether the mCherry harboring strains could be 
useful in tracking infection in vitro. RAW cells were grown to approximately 80% 
confluency on coverslips and infected with either 3902-mCh or 11168-mCh at an MOI of 
100. Coverslips were harvested and fixed in 4% paraformaldehyde at 30 minutes, 2 hours, 4 
hours, 8 hours, 12 hours, 24 hours, and 48 hours after infection. After at least 24 hours of 
fixation, coverslips were stained with an antibody to LAMP-1 and fixed with DAPI (Fig. 13). 
Immunofluorescence microscopy revealed mCherry expression within endosomal vesicles of 
RAW murine macrophages. Results are in general consistent with previous studies (35) and 
show that mCherry fluorescence appears to co-localize at a high rate with LAMP-1, an early 






 Here, we have attempted to develop two different cell culture models for use in in vitro 
study of Campylobacter genitourinary pathogenesis, with an aim towards identifying a 
suitable system of study for C. jejuni clone SA. Surprisingly, clone SA was much less 
efficient than the nonabortifacient strain NCTC11168 at infecting and surviving within AH-1 
ovine placental trophoblasts. This seems to indicate that the high virulence of this strain in 
pregnant animals is probably due more to its ability to actually gain access to the 
bloodstream and placenta, rather than a specific tropism for the placental tissue. This 
assumption is supported by the results of infections of RAW264.7 murine macrophages, in 
which IA3902 was significantly more invasive and persistent than NCTC11168. It has 
previously been shown that both IA3902 and NCTC11168 are able to produce evidence of 
bacteremia after oral inoculation at a relatively high rate (92% and 67%, respectively); 
however, only IA3902 causes uterine inflammation and abortion in pregnant Guinea pigs 
(10). Immune cells are recruited in large number to the fetus and placenta during pregnancy 
(36,37), and transport within these cells may represent a major mechanism via which C. 
jejuni localize there. The difference in survival and persistence in macrophages may thus 
present a deciding factor in pathogenesis of abortion. Previous studies utilizing a green 
fluorescent protein-expressing strain of C. jejuni showed a strong affiliation with 
granulocytes (neutrophils and, to a lesser extent, macrophages) in the bloodstream (19). 
Thus, if C. jejuni are "ferried" within immune cells in the bloodstream, macrophages are one 
likely candidate to serve as hosts. Indeed, they have been known to play a role in aiding the 
pathogenesis of a variety of exploitative bacteria, including providing a cue for expression of 
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virulence genes in Salmonella (38) and harboring and spreading Mycobacterium tuberculosis 
(39).  
 The apparently protective nature of progesterone against invasion by Campylobacter 
spp. is intriguing. We had hypothesized that a high level of progesterone would make the 
trophoblasts more susceptible to infection, since at the time of typical infection (the third 
trimester of pregnancy), serum and local uterine levels are relatively high in the ewe. 
Additionally, in driving fetal tolerance, progesterone's effects are largely anti-inflammatory; 
it promotes IL-10 synthesis in dendritic cells (40) and drives T cells towards a Th2 
phenotype (41). Thus, we would expect its presence to dampen immune response to C. 
jejuni; paradoxically, the data indicate that high levels of progesterone actually decrease 
infection of AH-1 ovine placental trophoblasts by C. jejuni. A drop in progesterone level may 
actually be required, then, prior to maximal C. jejuni invasion and replication; interestingly, 
it was noted in one of the first studies of C. jejuni abortion that progesterone levels were 
normal 48 hours prior to abortion but dropped precipitously immediately prior to the abortive 
event (5). Possibly, this could be attributed to gastrointestinal inflammation causing 
increased blood flow to the gut and liver; 96% of progesterone is metabolised during a single 
passage through these organs (42), which could be expected to significantly lower the 
peripheral concentration if blood flow were diverted there. As progesterone is essential in the 
maintenance of pregnancy (41,43), a large enough decrease could directly cause abortion to 
occur. However, while subclinical hepatitis and gastrointestinal inflammation is a possibility, 
most ewes show few clinical signs prior to the abortive event (5). It should also be noted that 
the effects of progesterone during pregnancy are far-reaching and complex, especially with 
regards to the immune system, and thus far understood to a rather scarce degree (44); hence, 
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at least some of its effects on the trophoblasts are likely to be multifactorial and rather 
difficult to untangle. That it did not have an effect on the bacteria themselves is not 
surprising (as C. jejuni do not possess a known progesterone receptor), and serves as further 
confirmation that its effect is likely to be in altering cellular pathways in the trophoblasts 
themselves. More extensive studies of gene and protein expression would be necessary to 
pinpoint the extent of progesterone’s influence upon these cells and its possible mechanisms 
for inducing a protective state against C. jejuni infection.  
 These studies have also demonstrated successful cloning of the mCherry gene into C. 
jejuni. The promoter of cmeABC was utilized for mCherry expression as it is moderately 
constitutively active in Campylobacter (26,45). However, its activity does not appear to be 
high enough to warrant its use as a promoter in this instance. While fluorescence in mCherry-
expressing strains was higher than that of the wt strains at times greater than 12 hours (Fig. 
9a), the difference was not impressively large; the lack of difference at earlier time points 
also suggests that expression of the mCherry protein was too low to be readily detectable 
unless bacteria are in high concentration. Addition of taurodeoxycholic acid to increase 
expression through the cmeABC promoter was highly successful in increasing fluorescence, 
but also caused severe growth restriction at the concentration used. Acetylsalicylic acid, 
which also would be expected to increase expression through the cmeABC promoter, did not 
cause a growth defect but also did not improve and actually somewhat decreased 
fluorescence values. Selection of a promoter with higher innate activity, such as the MOMP 
promoter (46,47), may provide at least a partial solution. However, there also appears to be a 
large fitness cost to strains of C. jejuni expressing the plasmid, with consequently low 
retention after 5 passages. It should be noted that our results in the first 5 days are similar to 
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Miller et al., who showed excellent retention of plasmids expressing gfp, yfp, and cfp at day 
5, but did not passage their cultures beyond that time (20). This still leaves open the question 
of whether the observed plasmid loss is specific to this plasmid construct or represents a 
general fitness cost to expression of other fluorescent proteins in C. jejuni.  
 Despite the obvious drawbacks of the mCherry strains created herein as a system for in 
vivo study of C. jejuni infection, the utility of the mCherry-expressing strains for in vitro 
microscopic studies of C. jejuni infection is evident. Visualization of bacteria within RAW 
murine macrophages facilitated determination of intracellular localization. The mCherry 
fluorescent protein has excellent proven tissue penetration (48,49) and would likely make an 
excellent candidate for in vivo tracking of Campylobacter infection if the problems outlined 
above could be overcome, e.g. via the use of a more active promoter or through chromosomal 
insertion of the mCherry gene.  
 In sum, we have identified a potential system for in vitro study of the pathogenesis of 
C. jejuni clone SA, as RAW264.7 murine macrophages seem to be permissive to infection 
and persistence of this strain. We have also determined that clone SA does not seem to have 
high pathogenicity for AH-1 ovine placental trophoblasts in an in vitro model, despite high 
tropism for these cells in vivo, and that progesterone seems to be protective for trophoblasts 
in spite of its anti-inflammatory effects during pregnancy.  
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Figure 1. Invasion and intracellular survival of two strains of Campylobacter jejuni in AH-1 
ovine placental trophoblasts. Data are expressed in log (cfu/ml) (mean ± SEM). * indicates p 
< 0.05, ** indicates p < 0.01.  



























Figure 2. Effects of progesterone on 11168 (A) and 3902 (B) invasion and intracellular 
survival in AH-1 ovine placental trophoblasts. Time = -4 represents inoculum values. Data 
are representative of three independent experiments, each performed in triplicate. Box 
represents second and third quartiles with line at mean, and min/max range is indicated. * = p 
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Figure 3. Effects of ß-estradiol on 11168 (A) and 3902 (B) invasion and intracellular 
survival in AH-1 ovine placental trophoblasts. Time = -4 represents inoculum values. Data 
are representative of three independent experiments, each performed in triplicate. Box 
represents second and third quartiles with line at mean, and min/max range is indicated.* = p 











































Figure 4. Invasion and intracellular survival of NCTC11168 (A) and IA3902 (B) in AH-1 
Ovine placental trophoblast cells treated with 1 µg/ml progesterone for 15 minutes, 3 hours, 
24 hours, or 48 hours prior to infection. Data are representative of two independent 
experiments, each performed in triplicate. Box represents second and third quartiles with line 
at mean, and min/max range is indicated.*, p < 0.05; **, p < 0.01.  
















































Figure 5. Pretreatment of NCTC11168 (A) or IA3902 (B) with 1.0 µg/ml progesterone (PH) 
or ß-estradiol (EH). C. jejuni were cultured in the presence of hormones indicated for 
approximately 20 hours prior to use in infection assays of AH-1 ovine placental trophoblasts. 
Data are representative of three independent experiments, each performed in triplicate. Box 
represents second and third quartiles with line at mean, and min/max range is indicated. 
 
 


































Figure 6. Invasion and intracellular survival of two strains of Campylobacter jejuni in 
RAW264.7 murine macrophages. Data are expressed in log (cfu/ml) (mean ± SEM). Data are 
representative of three independent experiments, each performed in triplicate. **, p < 0.001.  
 
 





















Figure 7. Motility of mCh-expressing C. jejuni strains as compared to wt strains. Mean is 
indicated for each strain. Differences between wt and mCh-harboring strains were not 





































Figure 8. Growth of mCherry-harboring strains of NCTC11168 and IA3902 as compared to 
their wt counterparts. Data are expressed as mean±SEM of OD600nm values. Data are 
representative of three independent experiments. *, 3902 > 3902-mCh and 11168 > 11168-








Figure 9. Normalized fluorescence values for 11168-mCh, 3902-mCh, and their wt 
counterparts (A). Normalized values represent average blank corrected relative fluorescence 
units (RFU)/average OD600nm (mean±SEM). Data are representative of three independent 
experiments. *, 3902-mCh > 3902 and 11168-mCh > 11168, p < 0.05; †, 3902-mCh > 3902, 
p < 0.001.  Figure 9B shows a representative image of C. jejuni 3902-mCh bacteria 
confirming expression of fluorescent mCherry protein; the 11168-mCh strain is similar in 
appearance.  




















Figure 10. Fluorescence values (mean ± SEM) of 11168-mCh and 3902-mCh grown in plain 
MH broth or MH broth containing 200 µg/ml acetylsalicylic acid (ASA). Data are 
representative of three independent experiments. †, 3902-mCh > 3902-mCh+ASA (p = 







Figure 11. Fluorescence values (mean±SEM) of 11168-mCh and 3902-mCh grown in plain 
MH broth or MH broth containing 25 mg/ml taurodeoxycholic acid (TCA). Data are 
representative of three independent experiments. **, 3902-mCh+TCA > 3902-mCh and 
11168-mCh+TCA > 11168-mCh, p < 0.01. †, 3902-mCh+TCA > 3902-mCh (p < 0.05) and 




Figure 12. Percent retention of the pRY112-pABC-mCh plasmid within C. jejuni strains 
NCTC11168 and IA3902 after serial passage in MH broth.  
  



















Figure 13. Representative image showing expression of mCherry fluorescent protein (red) by 
C. jejuni strain 3902-mCh within endosomal vesicles of RAW264.7 murine macrophages at 2 
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